NEWS | March 10, 2021

March 12 event features mRNA therapy pioneer Katalin Karikó

UC Davis School of Medicine and UC Davis Office of Research have partnered to provide an exciting opportunity to hear from a pioneer in RNA-mediated immune activation, Katalin Karikó, senior vice president at BioNTech RNA Pharmaceuticals.

Karikó will speak about the path of the development and science behind this exciting platform that is at the forefront of COVID-19 relief.

Register here to attend this virtual event; registration is required.

8–9 a.m.: Presentation

9–9:45 a.m.: Question & Answer Session

This is the latest offering in the Office of Research Distinguished Speaker Series in Research and Innovation, presented in partnership with the UC Davis Lung Center Seminar Series and co-hosted by the School of Medicine.